Bris­tol-My­ers teams up with Op­di­vo mak­er Ono Phar­ma­ceu­ti­cal on new I/O pro­grams

Bris­tol-My­ers Squibb $BMY has inked a li­cens­ing deal with long­time part­ner Ono Phar­ma­ceu­ti­cal to de­vel­op mul­ti­ple tu­mor-fight­ing pro­grams.

BMS is pay­ing $40 mil­lion up­front, and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER